Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7902]

CNIO researchers find effective drug combinations for glioblastoma in mice

CNIO researchers find effective drug combinations for glioblastoma in mice

$EHA 2019: Imetelstat in lower risk myelodysplastic syndromes refractory to erythropoietic stimulating agents$

EHA 2019: Imetelstat in lower risk myelodysplastic syndromes refractory to erythropoietic stimulating agents

EHA 2019: Introduction of a new fixed-duration targeted therapy with venetoclax plus obinutuzumab in previously untreated patients with chronic lymphocytic leukaemia and coexisting comorbidities

EHA 2019: Introduction of a new fixed-duration targeted therapy with venetoclax plus obinutuzumab in previously...

A heart failure drug to treat leukaemia: a promising new therapeutic approach

A heart failure drug to treat leukaemia: a promising new therapeutic approach

Radiation plus chemotherapy doesn't improve endometrial cancer recurrence-free survival

Radiation plus chemotherapy doesn't improve endometrial cancer recurrence-free survival

SIRT1 plays key role in chronic myeloid leukemia to aid persistence of leukemic stem cells

SIRT1 plays key role in chronic myeloid leukemia to aid persistence of leukemic stem cells

Three-drug combination helps curb the growth of deadly type of skin cancer

Three-drug combination helps curb the growth of deadly type of skin cancer

Physics could answer questions about breast cancer spreading to bones

Physics could answer questions about breast cancer spreading to bones

Study sheds light on how cells in the body can sense cancer

Study sheds light on how cells in the body can sense cancer

DNA nanorobots target HER2-positive breast cancer cells

DNA nanorobots target HER2-positive breast cancer cells

More from ecancer